<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01427192</url>
  </required_header>
  <id_info>
    <org_study_id>CSRPH</org_study_id>
    <nct_id>NCT01427192</nct_id>
  </id_info>
  <brief_title>Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension</brief_title>
  <acronym>CSRPH</acronym>
  <official_title>Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension (CSRPH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the differential short-term effect of nocturnal oxygen,
      acetazolamide tablets and nocturnal non-invasive positive pressure ventilation on symptoms,
      exercise capacity and nocturnal breathing disturbances in subjects with pulmonary
      hypertension and sleep related breathing disorders

        -  Trial with medicinal product
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>exercise capacity</measure>
    <time_frame>1 week</time_frame>
    <description>Assessment by the 6 minute walk distance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>1 week</time_frame>
    <description>Assessment by the short form of the SF 36 questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sleep related breathing disorders</measure>
    <time_frame>1 week</time_frame>
    <description>assessed by polysomnography according to standard techniques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemodynamics measured by echocardiography</measure>
    <time_frame>1 week</time_frame>
    <description>right ventricular dimension right ventricular over right atrial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>venous blood analysis</measure>
    <time_frame>1 week</time_frame>
    <description>C reactive protein NT-proBNP IL-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nocturnal oxygen desaturation</measure>
    <time_frame>1 week</time_frame>
    <description>Assessed by fingertip puleoxymetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>arterial blood analysis</measure>
    <time_frame>1 week</time_frame>
    <description>oxygenation electrolytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vigilance</measure>
    <time_frame>1 week</time_frame>
    <description>Assessed by the MURT test</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <condition>Breathing-Related Sleep Disorder</condition>
  <arm_group>
    <arm_group_label>acetazolamide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 week therapy, cross-over design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo tablet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One week, cross-over design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>supplemental oxygen during nights</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One week, cross-over design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-invasive ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One week, cross-over design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>room air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>room air applied via sham-oxygen-concentrator</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetazolamide</intervention_name>
    <description>250 mg bid</description>
    <arm_group_label>acetazolamide</arm_group_label>
    <other_name>Diamox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Supplemental oxygen</intervention_name>
    <description>Oxygen deliverded by nasal cannula</description>
    <arm_group_label>supplemental oxygen during nights</arm_group_label>
    <other_name>Oxygen concentrator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-invasive ventilation</intervention_name>
    <description>Bi-level non-invasive ventilation via nasal mask</description>
    <arm_group_label>Non-invasive ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Room air</intervention_name>
    <description>Room air applied via sham oxygen concentrator</description>
    <arm_group_label>room air</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo tablet</intervention_name>
    <description>Placebo tablet (Mannitol) similar to acetazolamide</description>
    <arm_group_label>Placebo tablet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  percapillary pulmonary hypertension diagnosed by right heart catheterisation -- stable
             therapy and clinical condition for at least 4 weeks

          -  sleep disordered breathing with apnea/hypopnea index &gt; 10 events/h and/or median
             nocturnal oxygen saturation &lt;90%

        Exclusion criteria:

          -  Pregnancy

          -  severe daytime hypoxemia (PaO2 &lt; 7.2 kPA)

          -  patients with predominantly obstructive sleep apnea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Respiratory Clinic, University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Ulrich S, Fischler M, Speich R, Bloch KE. Sleep-related breathing disorders in patients with pulmonary hypertension. Chest. 2008 Jun;133(6):1375-1380. doi: 10.1378/chest.07-3035. Epub 2008 Mar 13.</citation>
    <PMID>18339776</PMID>
  </reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2011</study_first_submitted>
  <study_first_submitted_qc>August 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2011</study_first_posted>
  <last_update_submitted>December 11, 2012</last_update_submitted>
  <last_update_submitted_qc>December 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breathing-Related Sleep Disorder</keyword>
  <keyword>Pulmonary Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetazolamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

